Yes, genetic markers can sometimes predict the progression and severity of neurological diseases. For example, mutations in the APOE gene are associated with an increased risk and earlier onset of Alzheimer's disease. Such markers enable clinicians to monitor patients more effectively and tailor treatment plans accordingly.
